Novartis Investigative Site

Paderborn, North Rhine-Westphalia 33098

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Follicular, Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

Studies at this site

• A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP) — Running, not enrolling
• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early